Sempeter Pri Gorici

Slovenia

2 total trials

Filter these 2 trials by phase, condition, sponsor and more.

Open in Search →

A Study to Compare Risankizumab to Vedolizumab in Adult Subjects With Moderate to Severe Ulcerative Colitis Ended recruitment

2024-518998-33-00 5 2025-07-23 Ulcerative Colitis
REIMAGINE 2: A research study to see how well CagriSema compared to semaglutide, cagrilintide and placebo lowers blood sugar and body weight … Ended

2022-502678-18-00 5 2023-11-07 Type 2 diabetes

Showing 1–2 of 2 trials